Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix in Endometriosis
NCT00619866Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Feb 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of elagolix in endometriosis (3 arms), sponsored by AbbVie Inc. Primary endpoint: Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain at 12 weeks. Started Feb 2008; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00619866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619866.